The Strategic Minerals Trade That’s Running Hot Again

When rates stop rising, the market usually chases whatever is loudest. But some of the sharpest moves come from the quiet corners where supply is tight and geopolitics matters.

One corner is the materials that sit inside the parts you never see: magnets, motors, sensors, and the industrial plumbing of electrification.

This stock could be a great opportunity.

Act Early (Sponsored)

The Crypto Foundation Is Already Set

Liquidity is rising, institutions are investing, and regulations are becoming friendlier.

The foundation is set for what could be a major market move.

Investors who act now may benefit most.

A 250-page digital system reveals how to grow crypto wealth safely, without risky speculation or constant stress.

Download now and claim $788 in bonuses—including the #1 crypto pick this cycle.

Access the Crypto Guide

Never Miss a Stock Alert Again!

We now send our daily picks via SMS too — so you’ll get the same high-conviction ideas, even if you miss the email.

👉 Click here to get stock picks by text and stay in the loop, always.

CRISPR Therapeutics | CRSP

Price: $56.19

CRSP heads into J.P. Morgan Healthcare Conference week with traders focused on one thing: whether its first commercial launch is moving from approved to adopted without getting bogged down in real-world friction.

These therapies are not like a pill launch where you just scale a sales force.

You need treatment centers ready, logistics aligned, payers on board, and patients starting therapy at a pace that makes the revenue curve feel real.

The other layer is the partnership structure.

Because Vertex leads commercialization and the economics are shared, CRSP’s near-term financial picture is less about headline sales and more about how quickly the launch gets through early costs and into durable profit sharing.

That nuance can confuse retail investors, but the stock still trades on confidence in the rollout.

Why it matters for you: CRSP can re-rate quickly if management signals steady patient starts and cleaner reimbursement coverage.

If the tone suggests a slow ramp or higher costs, expect volatility. This is a catalyst stock right now, so position sizing matters.

Crocs | CROX

Price: $85.36

Crocs keeps proving it is not just a meme brand.

The company is leaning into a disciplined playbook: cut costs, clean up channels, protect pricing, and keep returning capital to shareholders.

The biggest near-term headwind is North America demand, where management has been more cautious on promotions and wholesale activity to protect brand health.

That can pressure revenue in the short run, but it often helps rebuild stronger long-term unit economics.

HEYDUDE is still the swing factor. The wholesale reset is painful, but the company is trying to stabilize sell-through and improve how the brand shows up on shelves.

Meanwhile, Crocs has continued to push collaborations and product extensions that keep the core franchise relevant, especially internationally where growth has been steadier.

Why it matters for you: CROX is the rare discretionary name that can fund its own reset. If the consumer stays choppy, strong cash flow and cost discipline can matter more than perfect headline growth.

Quiet Setup (Sponsored)

Where Smart Money Moves Next

Warren Buffett is holding a record cash pile as traditional markets lose value and inflation erodes purchasing power.

His next move may surprise investors—not banks, not tech, but gold.

Many gold companies now trade at deep discounts while generating strong cash flow.

One major miner stands out for disciplined management and prime positioning in a renewed U.S. mining push.

This rare opportunity lets investors see what could come before any public disclosures.

Click here to learn more and get ahead of the next big move.

YETI | YETI

Price: $49.33

YETI is a premium brand that tends to live and die by one question: how much will consumers pay for quality when budgets tighten?

The stock has had a better year, but it still trades in that awkward zone where the brand is strong yet expectations can swing depending on spending data and holiday demand.

What YETI has going for it is category credibility. People buy once, then keep buying accessories and upgrades because the experience is consistent.

That is not a guarantee of growth, but it is a real moat in a world of copycat products.

The market is also constantly debating valuation here because premium brands can look expensive right before they look cheap, depending on how quickly earnings grow.

Why it matters for you: YETI is a steadier way to play discretionary than most trend-driven brands. If demand holds up and margins stay protected, the stock can grind higher.

If spending drops, it will not be immune, but it tends to fall less than flashier consumer stories.

SolarEdge | SEDG

Price: $34.33

SolarEdge is a turnaround stock again, and the market is starting to reward the narrative.

The latest catalyst is a fresh upgrade to Buy tied to progress on the company’s recovery plan and product momentum. The key issue is not whether solar demand exists.

It is whether SolarEdge can rebuild gross margin and defend share without getting dragged back into price wars and channel inventory problems.

There are a few reasons sentiment is improving. New product launches can help simplify installs and reduce friction.

U.S. manufacturing ramp and exports can help positioning, especially if buyers care more about supply chain diversification.

And if management uses an Investor Day to lay out mid-term margin targets above consensus, that can reset the stock’s valuation framework.

Why it matters for you: SEDG is still risky, but it has the kind of setup that can keep working if the turnaround is real.

If you are playing it, the main signal to watch is margin trajectory, not just revenue stabilization.

MP Materials | MP

Price: $63.82

MP has been one of the market’s cleanest expressions of strategic materials momentum.

The stock’s big move reflects a simple thesis: non-China supply chains matter more when geopolitics tightens, and magnets are a priority for EVs, defense systems, and industrial electrification.

Investors also like that MP is tied to a domestic asset base that policymakers can point to when talking about resilience and reshoring.

The nuance is important, though.

Mountain Pass is best known for light rare earths, while the heavy rare earths that can be critical for high-performance magnets are tougher to secure.

That is why headlines around alternative sourcing can move the stock so quickly. Traders start sketching upside scenarios, sometimes long before the operational reality catches up.

This is not a slow-and-steady compounder story today. It is a momentum story with a strategic narrative, and those can overshoot in both directions.

Why it matters for you: MP can keep running if the market stays focused on magnet supply chains and policy support.

But it is headline-sensitive, so treat it like a high-volatility position. If you want exposure, keep size modest and respect drawdowns.

📊 Stat of the Day: 75 bps

With the exception of Brazil and Japan, nearly all major global central banks cut interest rates in 2025.

The U.S. Federal Reserve cut another 75 bps in 2025 (25 bps in September, October, and December), adding to the 100 bps of cuts in 2024.

Rate cuts can extend runway for turnarounds and high-beta names, but they do not remove execution risk.

In markets like this, the best rallies still go to companies that pair a good macro tailwind with clean operational follow-through.